Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Rekombinanter CD39 Antikörper

Der Maus Monoklonal anti-CD39 Antikörper (Klon rCD39-8682) (ABIN7864885) detektiert spezifisch CD39 in IHC. Dieser Antikörper reagiert spezifisch mit Proben aus Human.
Produktnummer ABIN7864885
639,45 €
Zzgl. Versandkosten 20,00 € und MwSt
Lieferung nach: Deutschland
Lieferung in 6 bis 10 Werktagen

Kurzübersicht für Rekombinanter CD39 Antikörper (ABIN7864885)

Target

Alle CD39 (ENTPD1) Antikörper anzeigen
CD39 (ENTPD1) (Ectonucleoside Triphosphate diphosphohydrolase 1 (ENTPD1))

Antikörpertyp

Recombinant Antibody

Reaktivität

  • 122
  • 38
  • 29
  • 4
  • 4
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
Human

Wirt

  • 63
  • 57
  • 9
  • 8
  • 1
Maus

Klonalität

  • 95
  • 42
  • 1
Monoklonal

Konjugat

  • 86
  • 8
  • 7
  • 6
  • 6
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser CD39 Antikörper ist unkonjugiert

Applikation

  • 47
  • 46
  • 37
  • 23
  • 14
  • 13
  • 12
  • 6
  • 4
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Immunohistochemistry (IHC)

Klon

RCD39-8682
  • Verwendungszweck

    Recombinant CD39 / ENTPD1 (Marker of Tumor-specific T cells) Antibody

    Spezifität

    CD39, also known as ectonucleoside triphosphate diphosphohydrolase 1 (ENP1), is an integral membrane glycoprotein that acts as an extracellular nucleotide-hydrolyzing enzyme. CD39 inhibits ADP-induced platelet aggregation by hydrolyzing ADP to AMP, and ultimately generating Adenosine. Intracellular CD39 undergoes glycosylation at six N-glycosylation sites and translocates to the membrane in order to be an active enzyme. Alternative splicing gives rise to three CD39 isoforms, vascular, placenta I and placenta II. The placenta I isoform differs at the amino terminus whereas the placenta II isoform is missing amino acids 300-510 at the C-terminus. CD39 is expressed in vascular tissues including placenta, lung, skeletal muscle and kidney, as well as endothelium, smooth muscle, cardiac cells, lymphocytes, such as activated B cells, activated NK cells, macrophages, Dendridic cells and platelets. CD39 may be used as an anti-thrombic agent for pre-treating patients at risk for coronary artery occlusion and thrombic stroke.

    Aufreinigung

    200ug/ml of Ab purified from Bioreactor Concentrate by Protein A/G.

    Immunogen

    Recombinant full-length human CD39 protein

    Isotyp

    IgG1, kappa
  • Applikationshinweise

    Optimal working dilution should be determined by the investigator.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Konzentration

    200 μg/mL

    Buffer

    Prepared in 10 mM PBS with 0.05 % BSA & 0.05 % azide.

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    4 °C

    Informationen zur Lagerung

    Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C.Antibody is stable for 24 months. Non-hazardous. No MSDS required.
  • Target

    CD39 (ENTPD1) (Ectonucleoside Triphosphate diphosphohydrolase 1 (ENTPD1))

    Andere Bezeichnung

    CD39

    Hintergrund

    ATPDase, DKFZp686D194, DKFZp686I093, Ecto apyrase, Ecto ATP diphosphohydrolase, Ectonucleoside triphosphate diphosphohydrolase 1, ENTPD1, FLJ40921, FLJ40959, Lymphoid cell activation antigen, NTPDase 1, SPG64

    Human tonsil or lymph node.

    Molekulargewicht

    70-100 kDa

    Gen-ID

    953, 576612
Sie sind hier:
Chat with us!